Trial Profile
Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. Data from Russian Register of sJIA
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Aug 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 27 Aug 2015 New trial record